You are viewing: Japan Biosurgery Market analysis
Part of: Biosurgery Market (Global)

The Japan Biosurgery Market was valued at $718.7 Million in 2025 and projected to reach to $982 Million by 2030, representing a compound annual growth rate of 6.4%. Japan's biosurgery market is positioned for steady growth through 2030, supported by an aging population requiring advanced surgical interventions and a healthcare system committed to adopting cutting-edge technologies.

Japan Biosurgery Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Biosurgery Market Trends and Insights

  • Japan's advanced healthcare infrastructure and aging population drive demand for minimally invasive surgical solutions and hemostatic agents.
  • The market in Japan benefits from strong adoption of innovative biosurgical products in hospitals and surgical centers across the country. The biosurgery sector in Japan is characterized by increasing investment in surgical innovation and a growing preference for advanced wound management solutions.
  • Japan's regulatory environment supports rapid product approvals, enabling manufacturers to introduce cutting-edge biosurgical technologies.
  • Between 2025 and 2030, Japan is expected to see sustained growth driven by rising surgical volumes, an expanding geriatric population, and heightened awareness of infection prevention in Japan's healthcare system..

Key Market Statistics

  • CAGR (2025-2030) 6.4% CAGR
  • Market Size, 2025 ~USD 718.7 Million
  • Forecast, 2030 ~USD 982 Million
  • Country Japan

Japan Biosurgery Market Overview

Market Valuation :

Japan's biosurgery market is valued at USD 718.7 million in 2025, with projected growth to USD 982.0 million by 2030, representing a steady 6.4% CAGR.

Aging Population Driver :

Japan's rapidly aging demographic creates sustained demand for advanced surgical solutions, with elderly patients requiring more frequent minimally invasive procedures and hemostatic interventions.

Healthcare Infrastructure Excellence :

Japan's world-class healthcare system and high medical technology adoption rates accelerate the integration of innovative biosurgical products across hospitals and surgical centers.

Minimally Invasive Preference :

Strong market preference for minimally invasive surgical techniques in Japan drives consistent demand for biosurgical hemostats, sealants, and tissue adhesives.

Japan Biosurgery Market Dynamics

  • The market benefits from high healthcare spending, strong regulatory frameworks, and surgeon preference for innovative biosurgical solutions that reduce operative time and improve patient outcomes.
  • Hemostatic agents and tissue sealants are experiencing particular traction in Japanese operating rooms.
  • Continued investment in R&D by both domestic and international manufacturers will further expand product portfolios tailored to Japanese clinical needs and preferences..

Market Ecosystem

logo-mobile

Biosurgery Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Bone-graft substitutes, surgical sealants & adhesives, adhesion barriers, staple-line reinforcement, soft-tissue attachments, and hemostatic agents for hemostasis, tissue sealing, adhesion prevention, and tissue repair in surgical procedures. Advanced hemostasis, minimized risk of leaks and bleeding, improved tissue handling, and effective adhesion prevention. Ethicon’s powered stapling and energy devices deliver enhanced sealing, less tissue slippage, and optimized surgical recovery.
Biosurgery portfolio includes hemostats and sealants, adhesion barrier for preventing adhesions; and suture line reinforcement and sealing in cardiovascular and general surgery. Rapid surgical hemostasis, effective adhesion reduction, strong, consistent tissue sealing, broad multi-specialty versatility, and clinically proven reduction in postoperative complications and optimized surgical workflow.
Polymeric sealants, biological adhesives, skin and tissue closure products, and staple-line reinforcement agents for wound closure, spinal, cranial, and complex general surgery. Enables rapid, needle-free wound closure, strong adhesion even in high-tension and moist environments, reduced CSF and other fluid leaks, and lower risk of infection. Enables sutureless procedures and improved cosmetic outcomes with robust tissue support.
Synthetic and allograft bone grafts, staple-line reinforcement, soft-tissue attachments, dural sealants, and topical adhesives for craniofacial, spine, orthopaedic, and trauma applications. Excellent osteointegration, reliable watertight dural sealing (99% CSF leak prevention), absorbable biomaterials for long-term regeneration, and reduced need for autograft harvesting all supporting faster healing and complication risk reduction.
Biosurgery portfolio includes hemostatic agents, surgical sealants, absorbable sponges, and soft-tissue reinforcement for bleeding control and tissue closure used in open and minimally invasive surgeries. Accelerates natural clotting, delivers rapid, reliable hemostasis, reduces surgical air leaks, is easy to use even in complex fields, and offers thrombin-free, 100% plant-based and collagen-based options proven safe and effective in a wide range of specialties

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Japan's biosurgery market reaches USD 718.7 million in 2025 and is forecast to grow to USD 982.0 million by 2030 at a 6.4% CAGR.
    • Japan's aging demographic and advanced healthcare infrastructure create strong demand for innovative biosurgical products and hemostatic solutions.
    • Japan's regulatory framework enables rapid product adoption, supporting market expansion through continuous innovation in surgical technologies.
    • Rising surgical volumes and infection prevention priorities in Japan drive sustained growth in the biosurgery sector through 2030.

    Biosurgery Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment BONE MORPHOGENETIC PROTEINS (Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 6.4% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 15.83 (2025)
    Revenue Forecast (Billions) ~USD 21.59 (2030)
    Segments Covered Type, Origin, Application, End User, Product

    Japan Biosurgery Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Type

    • Albumin-Based Sealants & Adhesives
    • Allografts
    • Biological Meshes
    • Bone Morphogenetic Proteins
    • Collagen & Protein Adhesion Barriers
    • Collagen-Based Sealants & Adhesives
    • Combination Hemostatic Agents
    • Cyanoacrylate-Based Sealants & Adhesives
    • Demineralized Bone Matrix
    • Fibrin-Based Adhesion Barriers
    • Fibrin-Based Sealants & Adhesives
    • Gelatin-Based Sealants & Adhesives
    • Hyaluronic Acid-Based Adhesion Barriers
    • Natural Adhesion Barriers
    • Natural/Biological Sealants & Adhesives
    • Natural/Biological Surgical Sealants & Adhesives
    • Other Bone-Graft Substitutes
    • Other Natural/Biological Surgical Sealants & Adhesives
    • Other Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Other Synthetic Adhesion Barriers
    • Oxidized Regenerated Cellulose-Based Hemostatic Agents
    • Peg Hydrogel-Based Sealants & Adhesives
    • Peg-Based Adhesion Barriers
    • Regenerated Cellulose-Based Adhesion Barriers
    • Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Synthetic Adhesion Barriers
    • Synthetic Bone Grafts
    • Synthetic Meshes
    • Thrombin-Based Hemostatic Agents
    • Urethane-Based Sealants & Adhesives
    • Xenografts

    By Origin

    • Animal-Based Sealants & Adhesives
    • Human Blood-Based Sealants & Adhesives

    By Application

    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Other Applications
    • Reconstructive Surgery
    • Thoracic Surgery
    • Urological Surgery

    By End User

    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
    • Other End Users

    By Product

    • Adhesion Barriers
    • Bone-Graft Substitutes
    • Hemostatic Agents
    • Soft-Tissue Attachments
    • Staple-Line Reinforcement Agents
    • Surgical Sealants & Adhesives

    JAPAN: BIOSURGERY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS79.684.791.298.2105.9114.5123.9134.48.1
    CLINICS106111.9119.4127.5136.5146.2157168.87.2
    HOSPITALS417.5436.2460.7487515.8547.1581.3618.66.1
    OTHER END USERS43.945.447.449.651.954.557.260.24.9
    TOTAL647678.3718.7762.3810.1862.3919.49826.4

    Target Audience

    • Medical Device Manufacturers : Biosurgical product companies need Japan-specific market data to assess market size, growth potential, and competitive positioning for product launches and expansion strategies in this advanced healthcare market.
    • Healthcare Investors : Investment firms evaluating opportunities in Japan's healthcare sector require detailed market analysis to identify growth prospects, valuation benchmarks, and risk factors in the biosurgery segment.
    • Hospital & Surgical Center Administrators : Japanese healthcare facility leaders need market insights to inform procurement decisions, budget allocation for biosurgical products, and understanding of emerging technologies and best practices.
    • Market Research & Consulting Firms : Research organizations require Japan-specific biosurgery data to support client advisory services, competitive analysis, and strategic recommendations for healthcare industry stakeholders.
    • Regulatory & Policy Advisors : Regulatory consultants and healthcare policy experts need Japan market data to advise on market dynamics, reimbursement trends, and regulatory pathways for biosurgical product approvals.

    Reasons to Buy this Report

    • Japan-Specific Market Sizing : Obtain precise valuation data for Japan's biosurgery market with verified 2025 baseline (USD 718.7M) and 2030 forecast (USD 982.0M), enabling accurate business planning and investment decisions.
    • Demographic Insights : Understand how Japan's aging population structure directly impacts biosurgery demand, allowing companies to tailor product development and marketing strategies to this critical demographic segment.
    • Competitive Landscape Analysis : Gain intelligence on market dynamics specific to Japan, including local competitor positioning, regulatory environment, and adoption patterns for biosurgical innovations in Japanese healthcare.
    • Growth Opportunity Identification : Identify high-potential segments within Japan's 6.4% CAGR growth trajectory, including emerging applications in minimally invasive procedures and opportunities for market expansion.
    • Strategic Market Entry Planning : Develop informed go-to-market strategies for Japan with data on healthcare infrastructure capabilities, surgeon preferences, hospital procurement patterns, and reimbursement landscape.

    Frequently asked questions

    What is the current size of Japan's biosurgery market?

    Japan's biosurgery market is valued at USD 718.7 million in 2025 and is expected to reach USD 982.0 million by 2030.

    What is the projected growth rate for biosurgery in Japan?

    Japan's biosurgery market is projected to grow at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2030.

    What factors are driving growth in Japan's biosurgery market?

    Key drivers include Japan's aging population, advanced healthcare infrastructure, rising surgical volumes, and increased focus on infection prevention and minimally invasive procedures.

    Which biosurgical products are most in demand in Japan?

    Hemostatic agents, wound management solutions, and advanced surgical sealants are among the most sought-after biosurgical products in Japan's healthcare system.

    How does Japan's regulatory environment impact biosurgery market growth?

    Japan's supportive regulatory framework enables rapid product approvals and market entry, facilitating the adoption of innovative biosurgical technologies across the country.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the biosurgery market. Exhaustive secondary research was done to collect information on the biosurgery industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Biosurgery market.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global biosurgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biosurgery market. The primary sources from the demand side include ambulatory surgical centers, hospitals, Clinics, and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Biosurgery Market

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global biosurgery market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global biosurgery market was split into various segments and sub-segments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various biosurgery manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from biosurgery (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global biosurgery market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach and Top-down Approach)

    Biosurgery Market

    Data Triangulation

    After arriving at the global biosurgery market's overall size through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Biosurgery products are essential in surgical procedures, aiding in the repair of damaged tissues and bones. Surgeons utilize these products to stabilize skin, internal organs, and blood vessels, ensuring hemostasis and tissue integrity after injury or surgery. Key types include surgical sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents, all designed to enhance healing and prevent complications.

    Stakeholders

    • Transfection products manufacturing companies
    • Pharmaceutical & Biopharmaceutical Companies
    • Chemical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Development and Manufacturing Organizations (CDMOs)
    • Research Institutes and Universities 
    • Venture Capitalists & Investors
    • Government Associations

    Report Objectives

    • To define, describe, segment, and forecast the transfection technologies market by product type, method, application, end user, and region
    • To provide detailed information about the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the transfection technologies market in five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, along with their respective key countries
    • To profile the key players in the transfection technologies market and comprehensively analyze their core competencies2 and market shares
    • To track and analyze competitive developments, such as product launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the transfection technologies market
    • To benchmark players within the transfection technologies market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share/rank

    Get the Full Biosurgery Market Report

    Full forecast, segment splits, and company analysis for all Biosurgery Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status